Hip Fracture
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
M&
Merck & Co.RAHWAY, NJ
2 programs1
MK0677Phase 21 trial
Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.MK0677
Merck & Co.Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.
Clinical Trials (2)
Total enrollment: 683 patients across 2 trials
Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
Start: Sep 2005Est. completion: Aug 200783 patients
Phase 2Terminated
NCT00414830Merck & Co.Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.
Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.
Start: Jan 2005Est. completion: Sep 2009600 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space